跳至主要内容
临床试验/NCT02521129
NCT02521129Unknown1 期

A New Track Ablation Device for Liver Biopsy: A Feasibility Study

Samsung Medical Center0 个研究点目标入组 20 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
1 期
入组人数
20
主要终点
Number of participants with complications

研究概览

简要总结

The purpose of this study is to evaluate the effectiveness and safety of a new biopsy track ablation device for liver biopsy.

详细描述

Background:

  • Percutaneous biopsy for hepatic masses has a potential risk of bleeding and peritoneal tumor seeding.
  • A new device for biopsy track ablation has been invented to reduce the risk of bleeding and peritoneal tumor seeding.

Method:

  • Routine percutaneous biopsy for hepatic masses is performed.
  • Immediate after obtaining tissue, biopsy needle track is ablated with a new biopsy tract ablator.
  • Immediate (with ultrasound) and 24 hours (with CT scan) after procedure, occurrence of complications is evaluated.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with a hepatic mass on CT scan or MRI
  • patients who are referred for percutaneous biopsy of a hepatic mass
  • patients with normal range of platelet count and coagulation test

排除标准

  • pregnant women
  • patients with ascites
  • Uncooperative patients

结局指标

主要结局

Number of participants with complications

时间窗: within 24 hours after procedure

If procedure-related complications are suspected clinically, appropriate tests such as CT scan or Ultrasound are performed and complications are evaluated. If procedure-related complications are not suspected, non-contrast CT scan is performed at 24 hours after procedure and complications are evaluated.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hyunchul Rhim

professor

Samsung Medical Center

相似试验